Nancy E. Thomas, M.D., Ph.D., Associate Professor

 

   Education/Degrees

 

     University of Chicago (Chicago, IL), B.A. with Honors, 1980, Chemistry

     Rockefeller University (New York, NY) Ph.D., 1986, Biochemistry and Bioorganic Chemistry

     Cornell University Medical College (New York, NY) M.D., 1987, Medicine

 

   Postgraduate Training

 

     1987-88 Intern, Dept. of Surgery, Strong Memorial Hospital, University of Rochester, Rochester, NC

     1988-89 Post-doctoral Fellow, Dept. of Dermatology, Strong Memorial Hospital, University of Rochester, Rochester, NC

     1989-91 Resident, Dept. of Dermatology, Strong Memorial Hospital, University of Rochester, Rochester, NC

     1991-92 Chief Resident, Dept. Dermatology, Strong Memorial Hospital, University of Rochester, Rochester, NC

 

   Clinical and Research Interests

 

     Melanoma and dysplastic nevi

     Dermatologic surgery

     Digital imaging and mole mapping

 

       Research Studies

 

      The North Carolina Melanoma Study

      Melanoma NRAS/BRAF Mutations: A Population-Based Study

      Melanoma RAS/BRAF Mutation:  Heterogeneity-Risk-Prognosis  

 

   Selected Publications and Presentations

 

1.      N.E. Thomas and L.A. Diaz, Pruritus. 2002 Conn’s Current Therapy. Philadelphia, WB Saunders, Rakel, R.E. and Bope, E.T. (eds.), p 36-38 (2002).

2.      N.E. Thomas. Urticaria. Netter's Internal Medicine, Runge M. S. and Greganti A. (eds.). Icon Learning systems, Teterboro, NJ, p 1018-22 (2003).

3.      N.E. Thomas, A. Alexander, S. Edmiston, E. Parrish, R.C. Millikan, P. Groben, D. Ollila, and K. Conway, Tandem BRAF mutations in primary human melanomas. Proc Amer Assoc Cancer Res (2nd ed.), 44, 1357 (2003) (abst.).

4.      N.E. Thomas, S. Edmiston, A. Alexander, R.C. Millikan, P. Groben, D. Ollila, T. Hensing and K. Conway.  NRAS and BRAF mutations in primary human melanomas. .  J Invest Dermatol 121, # 0187 (2003) (abst.).

5.      N.E. Thomas, T. Hensing, D. Ollila.   Advances and Challenges in Melanoma:  Clinical Diagnosis, Sentinel Lymph Node Biopsy, Staging, and Medical Treatment Options. Skin and Aging, 48-57 (June 2003).

6.      N.E. Thomas, A. Alexander, S. Edmiston, E. Parrish, R. C. Millikan, M. Berwick, P. Groben, D. Ollila, D. Mattingly and K. Conway. Tandem BRAF Mutations in Primary Invasive Melanomas. J Invest Dermatol, 51:466-470, 2004.

7.      V.M. Muniz-Medina, H. Mehta, A. Sakko, N.E. Thomas, C.J. Der, J.M. Shields. The role of B-Raf in melanoma and colorectal carcinoma. Proc Amer Assoc Cancer Res, 45, 1166 (2004) (abst).

8.      Stitzenberg KB, Groben PA, Stern SL, Thomas NE, Hensing TA, Sansbury LB, Ollila DW.  "Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness <=1.0mm)."  Annals of Surgical Oncology, 2004;11(10):900-6.

9.      N.E. Thomas and P. Groben.  Invasive superficial spreading melanomas arising from clinically normal skin.  J Am Acad Dermatol, 51:466-470, 2004.